Effects of IL-6 and AG490 on Regulation of Stat3 Signaling Pathway and Invasion of Human Pancreatic Cancer Cells in Vitro

Overview

Journal J Exp Clin Cancer Res

Publisher Biomed Central

Specialty Oncology

Date 2010 May 21

PMID 20482858

Citations 50

Authors

Chen Huang

Guang Yang

Tao Jiang

Kejian Huang

Jun Cao

Zhengjun Qiu

Affiliations

Soon will be listed here.

Abstract

Background: Signal transducer and activator of transcription 3 (Stat3) is a member of the Janus-activated kinase(Jak)/Stat signaling pathway. Abnormal activation of Stat3 plays a critical role in metastasis and invasion in varieties of human tumors including pancreatic cancer. This study aimed to investigate the mechanisms of activation and blocking of the Stat3 signaling pathway and its effects on invasion and metastasis of human pancreatic cancer cells.

Methods: The Jak inhibitor AG490 and interleukin-6 (IL-6) were added to the culture media of human pancreatic cancer cells SW1990 and Capan-2, respectively. Cell growth was measured by MTT assays. Western blotting and immunocytochemistry were performed to detect phosphorylated Stat3 (p-Stat3) protein, while VEGF and MMP-2 mRNA and protein expression were examined with fluorescence quantitative polymerase chain reaction and Western blotting, respectively. The invasion ability of SW1990 and Capan-2 cells was determined by cell invasion assay.

Results: Stat3 was activated by IL-6 in Capan-2 cells; protein expression of p-Stat3 was increased significantly in Capan-2 cells. IL-6 remarkably promoted the growth of Capan-2 cells (P < 0.05), and VEGF and MMP-2 mRNA and protein expression were increased significantly. Also, IL-6 increased the invasion ability of Capan-2 cells. AG490 inhibited Stat3 activation in SW1990 cells. Western blotting and immunocytochemistry analysis showed that p-Stat3 protein expression was decreased significantly with AG490 treatment in SW1990 cells. AG490 remarkably inhibited the growth of Capan-2 cells (P < 0.05), and VEGF and MMP-2 mRNA and protein expression was decreased significantly. And AG490 decreased the invasion ability of SW1990 cells.

Conclusions: Abnormal activation of Stat3 plays an important role in the invasion and metastasis of pancreatic cancer. Activation and blocking of the Stat3 signaling pathway can affect invasion ability and expression of the VEGF and MMP-2 genes in pancreatic cancer cells. The Stat3 signaling pathway may provide a novel therapeutic target for treatment of pancreatic cancer.

Citing Articles

Interleukin-6 serves as a critical factor in various cancer progression and therapy.

Mohamed A, Ahmed A, Al Abdulmonem W, Olegovich Bokov D, Shafie A, Al-Hetty H Med Oncol. 2024; 41(7):182.

PMID: 38900329 DOI: 10.1007/s12032-024-02422-5.

Current progress and prospects for G protein-coupled estrogen receptor in triple-negative breast cancer.

Zhang D, Chen H, Wang J, Ji J, Imam M, Zhang Z Front Cell Dev Biol. 2024; 12:1338448.

PMID: 38476263 PMC: 10928007. DOI: 10.3389/fcell.2024.1338448.

The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors.

Zhao R, Hu Z, Zhang X, Huang S, Yu G, Wu Z Cell Commun Signal. 2024; 22(1):68.

PMID: 38273295 PMC: 10809652. DOI: 10.1186/s12964-023-01421-9.

CEP55, serving as a diagnostic marker gene for osteosarcoma, triggers the JAK2-STAT3-MMPs axis.

Yan Y, He J, Cheng W Ann Med Surg (Lond). 2024; 86(1):190-198.

PMID: 38222763 PMC: 10783210. DOI: 10.1097/MS9.0000000000001491.

A new approach: Evaluation of necroptosis and immune status enables prediction of the tumor microenvironment and treatment targets in pancreatic cancer.

Lu S, Hua J, Liu J, Wei M, Liang C, Meng Q Comput Struct Biotechnol J. 2023; 21:2419-2433.

PMID: 37090434 PMC: 10113923. DOI: 10.1016/j.csbj.2023.03.037.

References

Mora L, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R . Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res. 2002; 62(22):6659-66. View

Huang S . Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin Cancer Res. 2007; 13(5):1362-6. DOI: 10.1158/1078-0432.CCR-06-2313. View

Postier R . The challenge of pancreatic cancer. Am J Surg. 2003; 186(6):579-82. DOI: 10.1016/j.amjsurg.2003.08.018. View

Grunstein J, ROBERTS W, Mathieu-Costello O, Hanahan D, Johnson R . Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. Cancer Res. 1999; 59(7):1592-8. View

Hodge D, Hurt E, Farrar W . The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer. 2005; 41(16):2502-12. DOI: 10.1016/j.ejca.2005.08.016. View

Yu L, Cheng Y, Qiao M, Zhang Y, Wu Y . Activation of STAT3 signaling in human stomach adenocarcinoma drug-resistant cell line and its relationship with expression of vascular endothelial growth factor. World J Gastroenterol. 2005; 11(6):875-9. PMC: 4250601. DOI: 10.3748/wjg.v11.i6.875. View

Xie T, Wei D, Liu M, Gao A, Ali-Osman F, Sawaya R . Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene. 2004; 23(20):3550-60. DOI: 10.1038/sj.onc.1207383. View

Huang C, Cao J, Huang K, Zhang F, Jiang T, Zhu L . Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro. Cancer Sci. 2006; 97(12):1417-23. PMC: 11159136. DOI: 10.1111/j.1349-7006.2006.00340.x. View

Kusaba T, Nakayama T, Yamazumi K, Yakata Y, Yoshizaki A, Nagayasu T . Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors. J Clin Pathol. 2005; 58(8):833-8. PMC: 1770863. DOI: 10.1136/jcp.2004.023416. View

10.

Wei D, Le X, Zheng L, Wang L, Frey J, Gao A . Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene. 2003; 22(3):319-29. DOI: 10.1038/sj.onc.1206122. View

11.

Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z . Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature. 1996; 379(6566):645-8. DOI: 10.1038/379645a0. View

12.

Qiu Z, Huang C, Sun J, Qiu W, Zhang J, Li H . RNA interference-mediated signal transducers and activators of transcription 3 gene silencing inhibits invasion and metastasis of human pancreatic cancer cells. Cancer Sci. 2007; 98(7):1099-106. PMC: 11158338. DOI: 10.1111/j.1349-7006.2007.00485.x. View

13.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun M . Cancer statistics, 2007. CA Cancer J Clin. 2007; 57(1):43-66. DOI: 10.3322/canjclin.57.1.43. View

14.

Chang K, Wu M, Jones D, Chen F, Tseng Y . Activation of STAT3 in thymic epithelial tumours correlates with tumour type and clinical behaviour. J Pathol. 2006; 210(2):224-33. DOI: 10.1002/path.2041. View

15.

Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S . Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer. Cancer Lett. 2003; 201(1):107-16. DOI: 10.1016/s0304-3835(03)00482-8. View

16.

Scholz A, Heinze S, Detjen K, Peters M, Welzel M, Hauff P . Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer. Gastroenterology. 2003; 125(3):891-905. DOI: 10.1016/s0016-5085(03)01064-3. View

17.

Matsuyama Y, Takao S, Aikou T . Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas. J Surg Oncol. 2002; 80(2):105-10. DOI: 10.1002/jso.10106. View

18.

Suiqing C, Min Z, Lirong C . Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma. J Dermatol. 2005; 32(5):354-60. DOI: 10.1111/j.1346-8138.2005.tb00906.x. View

19.

Yang J, Liao X, Agarwal M, Barnes L, Auron P, Stark G . Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev. 2007; 21(11):1396-408. PMC: 1877751. DOI: 10.1101/gad.1553707. View

20.

Lee S, Lou W, Qureshi K, Mehraein-Ghomi F, Trump D, Gao A . RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells. Prostate. 2004; 60(4):303-9. DOI: 10.1002/pros.20072. View